GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo International PLC (TSX:ENDP) » Definitions » Shiller PE Ratio

Endo International (TSX:ENDP) Shiller PE Ratio : (As of May. 05, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Endo International Shiller PE Ratio?

Note: If the price history is too short, we do not calculate current Shiller PE for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Endo International Shiller PE Ratio Historical Data

The historical data trend for Endo International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo International Shiller PE Ratio Chart

Endo International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Endo International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Endo International's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Endo International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo International's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Endo International's Shiller PE Ratio falls into.



Endo International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Endo International's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Endo International's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/120.1096*120.1096
=0.000

Current CPI (Dec. 2023) = 120.1096.

Endo International Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -3.787 100.573 -4.523
201406 0.152 100.773 0.181
201409 -1.806 100.474 -2.159
201412 -0.404 99.576 -0.487
201503 -0.568 99.975 -0.682
201506 -1.669 100.573 -1.993
201509 -6.660 100.274 -7.977
201512 -0.731 99.676 -0.881
201603 -0.794 99.676 -0.957
201606 1.986 101.072 2.360
201609 -1.285 100.274 -1.539
201612 -19.982 99.676 -24.078
201703 -1.044 100.374 -1.249
201706 -8.323 100.673 -9.930
201709 -0.528 100.474 -0.631
201712 -2.107 100.075 -2.529
201803 -2.923 100.573 -3.491
201806 -0.354 101.072 -0.421
201809 -1.004 101.371 -1.190
201812 -1.747 100.773 -2.082
201903 -0.107 101.670 -0.126
201906 -0.625 102.168 -0.735
201909 0.000 102.268 0.000
201912 0.000 102.068 0.000
202003 0.000 102.367 0.000
202006 0.000 101.769 0.000
202009 0.000 101.072 0.000
202012 0.000 101.072 0.000
202103 0.000 102.367 0.000
202106 0.000 103.364 0.000
202109 0.000 104.859 0.000
202112 0.000 106.653 0.000
202203 0.000 109.245 0.000
202206 0.000 112.734 0.000
202209 0.000 113.431 0.000
202212 0.000 115.425 0.000
202303 0.000 117.618 0.000
202306 0.000 119.611 0.000
202309 0.000 120.708 0.000
202312 0.000 120.110 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Endo International  (TSX:ENDP) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Endo International Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Endo International's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo International (TSX:ENDP) Business Description

Traded in Other Exchanges
Address
Simmonscourt Road, Ballsbridge, First Floor, Minerva House, Dublin, IRL, 4
Endo International PLC is a specialty pharmaceutical company with a considerable presence in pain management, urology, orthopedics, endocrinology, bariatrics, and others. It operates in four segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals, and International Pharmaceuticals. The company generates maximum revenue from the Branded Pharmaceuticals segment. Some of its products include XIAFLEX, SUPPRELIN, PERCOCET, TESTOPEL, VASOSTRICT, ADRENALIN, and APLISOL.

Endo International (TSX:ENDP) Headlines

No Headlines